Live
IlluminaIllumina stock (US4523271090): Corporate Responsibility Report highlights genomics growth drivers - AD HOC NEWSEli LillyElil Lilly buys a Bay Area Y Combinator alum for up to $202M - The Business JournalsPfizerPharma sector doubles down on AI amid hopes of slashing costs, timelines - ReutersFierceBiotechGHO Capital, CBC Group plan to merge, forming $21B healthcare investment firmEli LillyEli Lilly Acquires Engage Bio | PharmExec - Pharmaceutical ExecutiveMettler ToledoMettler-Toledo stock (US5926881054): analysts’ targets and earnings keep focus on precision instru - AD HOC NEWSLabCorpLabcorp Launches AI-Powered App to Help Patients Understand Test Results - Clinical Lab ProductsRevvityRevvity Inc. stock (US76155R1086): investors weigh latest earnings and diagnostics focus - AD HOC NEWSEli LillyCollaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation - Genetic Engineering and Biotechnology NewsClinical OMICsEarly Medical Care Linked to Rapid Gut Microbiome Shifts in Amazonian Indigenous CommunitiesClinical OMICsAI Shows Value for Breast Cancer PredictionMerck & Co.EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study - TradingView
10x Genomics News 26. März 2026

10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus

10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.